Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HuMAB companies -- Ignore unavailable to you. Want to Upgrade?

To: A.J. Mullen who wrote (957)	2/2/2010 1:46:48 AM
From: DewDiligence_on_SI	Read Replies (1) \| Respond to of 1022

>Are European analysts harder-nosed than Americans< By and large, European drug/biotech analysts do more analysis and less cheerleading than their US counterparts. For instance, Europeans analysts will never start a question by saying, “Congratulations on a great quarter.” If you haven’t already done so, listen to one of NVS’ or Roche’s quarterly CC’s. The difference I’m talking about will be readily apparent.